JP2024538730A5 - - Google Patents

Info

Publication number
JP2024538730A5
JP2024538730A5 JP2024521109A JP2024521109A JP2024538730A5 JP 2024538730 A5 JP2024538730 A5 JP 2024538730A5 JP 2024521109 A JP2024521109 A JP 2024521109A JP 2024521109 A JP2024521109 A JP 2024521109A JP 2024538730 A5 JP2024538730 A5 JP 2024538730A5
Authority
JP
Japan
Prior art keywords
methylene
substituted
pharmaceutical composition
atoms
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024521109A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024538730A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/077702 external-priority patent/WO2023060200A1/en
Publication of JP2024538730A publication Critical patent/JP2024538730A/ja
Publication of JP2024538730A5 publication Critical patent/JP2024538730A5/ja
Pending legal-status Critical Current

Links

JP2024521109A 2021-10-07 2022-10-06 がん及び腫瘍を治療するための方法 Pending JP2024538730A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163253332P 2021-10-07 2021-10-07
US63/253,332 2021-10-07
PCT/US2022/077702 WO2023060200A1 (en) 2021-10-07 2022-10-06 Methods for treating cancers and tumors

Publications (2)

Publication Number Publication Date
JP2024538730A JP2024538730A (ja) 2024-10-23
JP2024538730A5 true JP2024538730A5 (https=) 2025-10-15

Family

ID=85804784

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024521109A Pending JP2024538730A (ja) 2021-10-07 2022-10-06 がん及び腫瘍を治療するための方法

Country Status (6)

Country Link
US (1) US20240408082A1 (https=)
EP (1) EP4412613A4 (https=)
JP (1) JP2024538730A (https=)
CN (1) CN118369101A (https=)
CA (1) CA3234699A1 (https=)
WO (1) WO2023060200A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7025416B2 (ja) 2016-06-06 2022-02-24 ビヨンドスプリング ファーマシューティカルズ，インコーポレイテッド 好中球減少症を低減させるための組成物および方法
BR112019015974A2 (pt) 2017-02-01 2020-03-31 Beyondspring Pharmaceuticals, Inc. Método para reduzir neutropenia
CA3215047A1 (en) 2021-04-09 2022-10-13 Lan Huang Therapeutic compositions and methods for treating tumors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005212399B2 (en) * 2004-02-04 2011-09-22 Nereus Pharmaceuticals, Inc. Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
AU2016229294B2 (en) * 2015-03-06 2021-11-04 Beyondspring Pharmaceuticals, Inc. Method of treating cancer associated with a RAS mutation
MX2021001762A (es) * 2018-08-16 2021-04-19 Beyondspring Pharmaceuticals Inc Metodo y composicion para estimular la respuesta inmunitaria.
JP2022513038A (ja) * 2018-11-14 2022-02-07 ビヨンドスプリング ファーマシューティカルズ，インコーポレイテッド チューブリン結合薬を使用する癌の治療方法

Similar Documents

Publication Publication Date Title
JP2024538730A5 (https=)
JP2021063088A5 (https=)
CN101142198B (zh) 用于治疗疾病的异*唑坎布雷它斯丁衍生物
EP3856345A1 (en) Process of manufacture of a compound for inhibiting the activity of shp2
JP2020507589A5 (https=)
JP2024513505A5 (https=)
JP2006523216A5 (https=)
JP2019515884A5 (https=)
JP2006501176A5 (https=)
JP2007511504A5 (https=)
JP2006511534A5 (https=)
JP2002525329A5 (https=)
JP2022521081A (ja) Ｈｂｖ感染若しくはｈｂｖ誘導性疾患の治療において有用なアミド誘導体
EP2455081A1 (en) S1P1 receptor agonists for use in the treatment of crohn's disease
JP2007505044A5 (https=)
JP2021536472A5 (https=)
JP2005501825A5 (https=)
JP2022502378A5 (https=)
JP2025509830A5 (https=)
JP2003532724A5 (https=)
JP2023541040A5 (https=)
JP2023524274A5 (https=)
WO2021062168A1 (en) Synthetic sphingolipid inspired molecules with heteroaromatic appendages, methods of their synthesis and methods of treatment
JP2005503411A5 (https=)
CN102190656B (zh) 含有五元杂环的噁唑烷酮抗菌素